Indications：
Used for moderate to severe active rheumatoid arthritis.
It is the first and only soluble CTLA4-Fc fusion protein approved for sale in mainland China, and the first and only selective T-cell co-stimulation modulator in the autoimmune disease therapeutic area worldwide.